Oklo Co-Founders Dump $28M in Stock Ahead of Q1 Earnings

NEW YORK, May 7 —

On May 1, 2026, Oklo Inc.'s two co-founders, CEO Jacob Dewitte and COO Caroline Cochran, each sold approximately 200,000 shares in a single session at prices between $69.06 and $70.95, generating roughly $14.05 million apiece, per Form 4 disclosures. That combined $28 million exit landed eleven days before Q1 2026 earnings, expected around May 12. Add $51.26 million in total net insider selling across all executives and directors over the prior 90 days, with zero purchases recorded in the same window, and the filing pattern earns a closer look.

Two Founders, One Date

The precision of the May 1 filings is the first thing worth understanding. Dewitte, a co-founder and 10% holder, filed six separate Form 4 disclosures covering that single day, with individual tranches ranging from 16,907 shares to 60,000. The largest block, 60,000 shares at $70.19, generated $4,211,400. Cochran, co-founder and COO holding the same 10% stake, filed an identical pattern: six tranches, the same price range, the same aggregate proceeds of approximately $14.05 million, the same largest tranche of 60,000 shares at $70.19 for $4,211,400.

Whether either set of trades was executed under a pre-scheduled 10b5-1 plan is the central unanswered question. A properly structured 10b5-1 plan, established during a non-material information window, provides a legal safe harbor and meaningfully reduces the informational signal of the sale. That confirmation has not appeared in publicly referenced disclosures. Until it does, the filings speak for themselves.

Nobody Bought

The co-founders were not alone. CFO Richard Craig Bealmear sold 16,216 shares at $69.92 on May 1 for $1.13 million, having exercised options the same day at $3.18 per share, a standard exercise-and-sell sequence. He had also sold 16,342 shares on April 1 at $51.08 for $834,749, a date on which Dewitte and Cochran each sold shares at prices ranging from approximately $48.41 to $51.20 per share. Director Richard Kinzley and director John M. Jansen sold in late March. CTO Patrick Joseph Schweiger also sold in late March.

Separately, Oklo filed an 8-K on April 14, 2026 disclosing a director or principal officer departure or appointment under Item 5.02, per the SEC filing. The broader picture across 90 days: $51.26 million sold, zero purchased, at every level of the corporate hierarchy.

The Valuation Math

Oklo shares trade at $73.52 with a market capitalization of approximately $12.79 billion. The company reported no trailing-twelve-month revenue and negative free cash flow of approximately $80 million, consistent with its pre-commercial status. Owning a stake at $12.79 billion means underwriting both the technical case, that small modular reactors work at commercial scale, and the regulatory case, that the NRC licensing path clears on schedule. Those are long-duration assumptions.

The quarterly EPS picture is mixed. The most recent quarter came in at -$0.07, beating estimates of -$0.11 by four cents. The prior two quarters missed: -$0.18 against -$0.11 estimated, and -$0.20 against -$0.12 estimated. The cash burn is consistent even when the beat-or-miss line fluctuates.

The May 12 Test

Q1 2026 earnings, expected around May 12, represent the next hard data point. Consensus analysts hold a price target of $91.36, roughly 24% above the current price of $73.52, suggesting the street sees meaningful upside from here. That gap is notable precisely because it means the insiders sold at a material discount to where analysts believe the stock belongs, whether that reflects disciplined diversification or a more sober internal read is exactly the question the filing pattern cannot answer on its own.

The bearish case is clean: two 10% holders who built this company liquidated $28 million in coordinated fashion less than two weeks before a scheduled earnings release, while the business carries no revenue and burns $80 million in annual free cash flow. The mitigating case requires the 10b5-1 plan disclosure, and that disclosure remains unconfirmed. The pattern warrants watching on May 12, when the company will have an opportunity to contextualize both the quarter and the selling activity.

Run the free Oklo Inc. deep-dive → basisreport.com/stock/oklo

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Is Oklo stock worth buying right now?

Oklo trades at $73.52 with a consensus analyst price target of $91.36, implying roughly 24% upside per Yahoo Finance fundamentals. However, the company has no trailing-twelve-month revenue, burns approximately $80 million in free cash flow annually, and insiders have sold $51.26 million net over the past 90 days with zero purchases — a combination that warrants caution even against an optimistic analyst consensus.

Why did Oklo insiders sell over $51 million in stock?

Per Form 4 disclosures aggregated over the past 90 days, Oklo executives and directors collectively sold approximately $51.26 million in shares with zero purchases recorded. The sales span the CEO, COO, CFO, CTO, and two directors. Whether any of these transactions were executed under pre-scheduled 10b5-1 plans, which would reduce their informational weight, has not been confirmed in publicly referenced disclosures.

When are Oklo Q1 2026 earnings?

Oklo's Q1 2026 earnings release is expected around May 12, 2026, per news coverage citing a calendar date. The report will be the next hard data point for investors evaluating the company's pre-commercial burn rate and any commentary management offers on the recent insider selling activity.

Did Oklo CEO Jacob Dewitte sell shares in 2026?

Yes. On May 1, 2026, Dewitte sold approximately 200,000 shares across six disclosed tranches at prices ranging from $69.06 to $70.95, generating total proceeds of approximately $14.05 million, per Form 4 filings. He also sold shares on April 1, 2026 at prices ranging from approximately $48.41 to $51.20 per share.

Does Oklo have revenue yet?

No. Oklo reported zero trailing-twelve-month revenue and negative free cash flow of approximately $80 million, consistent with its pre-commercial operating status, per Yahoo Finance fundamentals. The company is developing small modular nuclear reactors and has not yet reached commercial operation.